Skip to main content
. 2023 May 11;66(3):E274–E281. doi: 10.1503/cjs.012122

Table 6.

De novo emergency group compared with decompensated group — postoperative outcomes

Outcome De novo group Decompensated group p value
Adverse events per patient, mean ± SD 0.4 ± 0.8 0.6 ± 0.9 0.002
Risk of having any adverse events adjusted for age, OR (95% CI) 1.81 (1.04–3.13) 0.035
Adverse events, no. (%)
 Surgical site infections 4/584 (0.7) 4/69 (5.8) 0.006
 Systemic infections including urinary tract infections 63/586 (10.8) 13/69 (18.8) 0.07
 Neuropathic pain 88/586 (15.0) 11/69 (15.9) 0.86
 Delirium 52/586 (8.9) 7/69 (10.1) 0.82
 Dural tear 50/548 (9.1) 10/64 (15.6) 0.12
 Pneumonia 19/586 (3.2) 6/69 (8.7) 0.04
 Dysphagia 15/586 (2.6) 1/69 (1.5) 0.72
 Deep vein thrombosis 2/83 (2.4) 0/20 (0.0) > 0.99
 Pulmonary embolism 3/83 (3.6) 0/20 (0.0) 0.61
 Neurologic deterioration 5/83 (6.0) 1/20 (5.0) > 0.99
 Cord injury 0/44 (0.0) 0/15 (0.0) NA
 Nerve root injury 0/44 (0.0) 0/15 (0.0) NA
 CSF leak meningocele 0/83 (0.0) 0/20 (0.0) NA
 Hematoma 2/83 (2.4) 0/20 (0.0) > 0.99
 Wound dehiscence 3/83 (3.6) 1/20 (5.0) > 0.99
 Hardware malposition 1/44 (2.3) 0/15 (0.0) > 0.99
 Massive blood loss or transfusion 0/44 (0.0) 1/15 (6.7) 0.25

CI = confidence interval; CSF = cerebrospinal fluid; NA = not applicable; OR = odds ratio; SD = standard deviation.

Differing denominators indicates missing data for some patients in some categories.